Skip to main content
CivixlyCivixly
HomeFederal GovernmentState GovernmentLearnCommunityFeedback
Account
Menu
HomeFederal GovernmentState GovernmentLearnCommunityFeedback
Account
Civixly

Find representatives, follow federal and state legislation, and connect public records to the people and institutions responsible for them.

Explore

Federal governmentState governmentCivics guidesInstall Civixly

About the data

About CivixlyMethodologyData sources

Trust and support

Send feedback or a correctionPrivacy and data controlsSecurity contactCommunity

State Government / Louisiana / Legislation / SB 169

SB 169Session 2026SenateBecame law

GENETICS: Provides relative to biomarker testing. (gov sig) (EN NO IMPACT See Note)

No separate bill overview is currently available from the source.

Latest development · May 29, 2026

Signed by the Governor. Becomes Act No. 469.

Civixly approval

No ratings yet

0 ratings

Not enough ratings yet. Public approval appears at 5+ ratings.

Your view
0 comments
Source record ↗
Session
2026
Introduced
Feb 25, 2026
Latest passage
May 12, 2026
TopicsSponsorsActionsDiscussion

Topics and classification

Document type

Bill

Sponsors

Primary sponsors are listed before cosponsors and other sponsoring entities.

Primary sponsorKirk Talbot
cosponsorTehmi Chassion

Action timeline

Newest action first. Action language is supplied by the state source.

View full action timeline20 actions⌄
  1. May 29, 2026

    Signed by the Governor. Becomes Act No. 469.

    Became LawExecutive SignatureSenate
  2. May 29, 2026

    Effective date 5/29/2026.

    Senate
  3. May 25, 2026

    Signed by the Speaker of the House.

    House
  4. May 21, 2026

    Sent to the Governor by the Secretary of the Senate.

    Executive ReceiptSenate
  5. May 20, 2026

    Enrolled. Signed by the President of the Senate.

    EnrolledSenate
  6. May 19, 2026

    Amendments proposed by the House read and concurred in by a vote of 34 yeas and 0 nays.

    Senate
  7. May 12, 2026

    Read third time by title, roll called on final passage, yeas 97, nays 0. Finally passed, ordered to the Senate.

    PassageHouse
  8. May 12, 2026

    Received from the House with amendments.

    ReceiptSenate
  9. May 11, 2026

    Scheduled for floor debate on 05/12/2026.

    House
  10. May 7, 2026

    Read by title, amended, passed to 3rd reading.

    Reading 3House
  11. May 6, 2026

    Reported without Legislative Bureau amendments.

    House
  12. May 5, 2026

    Referred to the Legislative Bureau.

    House
  13. Apr 29, 2026

    Reported with amendments (11-0). To be recommitted to the Committee on Appropriations.

    Committee Passage FavorableHouse
  14. Apr 15, 2026

    Read by title, under the rules, referred to the Committee on Insurance.

    Referral CommitteeHouse
  15. Apr 14, 2026

    Read by title, passed by a vote of 35 yeas and 0 nays, and sent to the House. Motion to reconsider tabled.

    PassageSenate
  16. Apr 14, 2026

    Received in the House from the Senate, read by title, lies over under the rules.

    House
  17. Apr 13, 2026

    Read by title. Ordered engrossed and passed to third reading and final passage.

    Senate
  18. Apr 8, 2026

    Reported favorably.

    Committee Passage FavorableSenate
  19. Mar 9, 2026

    Introduced in the Senate; read by title. Rules suspended. Read second time and referred to the Committee on Insurance.

    Referral CommitteeSenate
  20. Feb 25, 2026

    Prefiled and under the rules provisionally referred to the Committee on Insurance.

    FilingReferral CommitteeSenate

SB 169 discussion

0 comments across 0 threads

Sign in to join the discussion.Comments are publicly visible.

Loading comments...

State legislative data provided by Open States and linked legislature sources when available.

Civixly tracks state bill actions, passage dates, and sponsors. Member-level state roll-call histories are not included.

Source data last updated Oct 31, 2026.